Abstract
Aims Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the 9th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA) Methods Eighty-three international experts met in Münster for 2 days in September 2023. Key findings are as follows: (i) Active rhythm and results management should be part of the default initial treatment for all suitable patients with AF. (ii) Patients with device-detected AF have a low burden of AF and a low risk of stroke. Anticoagulation prevents some strokes and also increases major but non-lethal bleeding. (iii) More research is needed to improve stroke risk prediction in patients with AF, especially in those with a low AF burden. Biomolecules, genetics, and imaging can support this. (iv) The presence of AF should trigger systematic workup and comprehensive treatment of concomitant cardiovascular conditions. (v) Machine learning algorithms have been used to improve detection or likely development of AF. Cooperation between clinicians and data scientists is needed to leverage the potential of data science applications for patients with AF.Conclusions Patients with AF and a low arrhythmia burden have a lower risk of stroke and other cardiovascular events than those with a high arrhythmia burden. Combining active rhythm control, anticoagulation, rate control, and therapy of concomitant cardiovascular conditions can improve the lives of patients with AF.
Original language | English |
---|---|
Article number | euae070 |
Number of pages | 18 |
Journal | EP Europace |
Volume | 26 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2024 |
Keywords
- AFNET
- Anticoagulation
- Artificial intelligence
- Atrial cardiomyopathy
- Atrial fibrillation
- Biomarkers
- Bleeding
- Catheter ablation
- Cognitive function
- Consensus statement
- Cost
- Dementia
- EHRA
- Guidelines
- Heart failure
- Integrated care
- Outcomes
- Quality of care
- Research
- Research priorities
- Rhythm management
- Screening
- Stroke
- Technology
- Humans
- Atrial Fibrillation/complications diagnosis epidemiology
- Stroke/etiology prevention & control
- Risk
- Hemorrhage
- Anticoagulants/therapeutic use